4Front Ventures (FFNTF) 10-Q 2022 Q2 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

Commission File Number

000-56075

4Front Ventures Corp.

(Exact name of registrant as specified in its charter)

British Columbia	83-4168417
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

5060 N. 40th Street

Suite 120

Phoenix, Arizona 85018

(Address of principal executive offices

and

zip code)

Registrant’s telephone number, including area code: (602)

633-3067

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Class A Subordinate Voting Shares, no par value	FFNTF	OTCQX
	FFNT	CSE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act

of

1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act:

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act).    Yes  ☐    No  ☒

As of August

15

, 2022, the registrant had 636,636,686 Class A subordinate voting shares outstanding.

4Front Ventures Corp.

FORM

10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements (unaudited)
	Condensed Consolidated Interim Balance Sheets		1
	Condensed Consolidated Interim Statements of Operations		2
	Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity		3
	Condensed Consolidated Interim Statements of Cash Flows		5
	Notes to Condensed Consolidated Interim Financial Statements (unaudited)		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		38
Item 4.	Controls and Procedures		38
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings		40
Item 1A.	Risk Factors		40
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		41
Item 3.	Defaults Upon Senior Securities		41
Item 4.	Mine Safety Disclosures		41
Item 5.	Other Information		41
Item 6.	Exhibits		42
Signatures			43

i

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

4FRONT VENTURES CORP.

CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS (unaudited)

As of June 30, 2022 and December 31, 2021

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

	June 30, 2022			December 31, 2021
ASSETS
Current assets:
Cash	$	6,032		$	22,581
Accounts receivable, net		5,844			1,946
Other receivables		33			289
Current portion of lease receivables		3,405			3,630
Inventory		28,837			20,087
Current portion of notes receivable		—			109
Prepaid expenses		2,974			2,232
Total current assets		47,125			50,874
Property, plant, and equipment, net		58,967			42,633
Lease receivables		6,541			6,748
Intangible assets, net		54,239			26,246
Goodwill		42,037			23,155
Right-of-use assets		106,406			100,519
Deposits		5,142			5,364
TOTAL ASSETS	$	320,457		$	255,539
LIABILITIES AND SHAREHOLDERS’ EQUITY
LIABILITIES
Current liabilities:
Accounts payable	$	6,391		$	2,131
Accrued expenses and other current liabilities		13,031			9,411
Taxes payable		29,651			23,968
Derivative liability		428			3,502
Current portion of contract liabilities		1,535			—
Current portion of convertible notes		—			2,784
Current portion of lease liability		4,121			3,629
Current portion of notes payable and accrued interest		8,235			3,413
Total current liabilities		63,392			48,838
Convertible notes		15,205			14,641
Notes payable and accrued interest from related party		49,366			48,266
Long term notes payable		10,128			1,709
Long term accounts payable		1,200			1,200
Contract liabilities		2,000			—
Contingent consideration payable		—			2,393
Construction finance liability		16,000			—
Deferred tax liability		6,884			7,849
Lease liability		101,380			93,111
TOTAL LIABILITIES		265,555			218,007
SHAREHOLDERS’ EQUITY
Equity attributable to 4Front Ventures Corp.		302,502			274,120
Additional paid-in capital		53,625			52,197
Deficit		(301,307	)		(288,857	)
Non-controlling interest		82			72
TOTAL SHAREHOLDERS’ EQUITY		54,902			37,532
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	320,457		$	255,539

See accompanying notes to financial statements.

1

4FRONT VENTURES CORP.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS (unaudited)

For the Three and Six Months Ended June 30, 2022 and 2021

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
REVENUE
Revenue from sale of goods	$	25,488		$	24,452		$	48,571		$	44,532
Real estate income		2,951			2,669			5,916			5,559
Total revenues		28,439			27,121			54,487			50,091
Cost of goods sold		(16,123	)		(10,816	)		(28,717	)		(19,941	)
Gross profit		12,316			16,305			25,770			30,150
OPERATING EXPENSES
Selling and marketing expenses		6,327			6,714			11,493			11,871
General and administrative expenses		6,566			5,083			14,210			10,248
Depreciation and amortization		1,123			861			1,970			1,635
Transaction and restructuring related expenses		2,009			—			2,009			—
Equity based compensation		390			2,979			1,428			5,375
Total operating expenses		16,415			15,637			31,110			29,129
(Loss) Income from operations		(4,099	)		668			(5,340	)		1,021
Other income (expense)
Interest income		—			8			2			11
Interest expense		(3,418	)		(2,901	)		(6,038	)		(5,362	)
Amortization of loan discount upon conversion of debt to equity		—			—			—			(2,915	)
Change in fair value of derivative liability		1,774			(311	)		3,074			(2,843	)
Change in contingent consideration payable		2,393			—			2,393			—
Loss on lease termination		—			(331	)		—			(1,210	)
Other		(154	)		—			(51	)		—
Total other income (expense), net		595			(3,535	)		(620	)		(12,319	)
Net loss before income taxes		(3,504	)		(2,867	)		(5,960	)		(11,298	)
Income tax expense		(3,042	)		(3,351	)		(6,480	)		(6,004	)
Net loss		(6,546	)		(6,218	)		(12,440	)		(17,302	)
Net income attributable to non-controlling interest		5			5			10			10
Net loss attributable to shareholders	$	(6,551	)	$	(6,223	)	$	(12,450	)	$	(17,312	)
Basic and diluted loss per share	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.03	)
Weighted average number of shares outstanding, basic and diluted		636,653,975			587,218,794			628,175,765			573,108,183

See accompanying notes to condensed interim financial statements.

2

4FRONT VENTURES CORP.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (unaudited)

For the Six Months Ended June 30, 2022 and 2021

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

	Share Capital
	Shares		Amount		Additional Paid-In Capital		Deficit			Total 4Front Ventures Corp. Shareholders’ Equity			Non- Controlling Interest		Total Shareholders’ Equity
Balance, December 31, 2021		594,181,604	$	274,120	$	52,197	$	(288,857	)	$	37,460		$	72	$	37,532
Shares issued for NECC pursuant to acquisition		28,571,428		18,200		—		—			18,200			—		18,200
Share-based compensation		—		—		1,038		—			1,038			—		1,038
Conversion of notes to equity		6,235,512		3,122		—		—			3,122			—		3,122
Shares issued with exercise of warrants		88,659		50		—		—			50			—		50
Net loss		—		—		—		(5,899	)		(5,899	)		5		(5,894	)
Balance, March 31, 2022		629,077,203	$	295,492	$	53,235	$	(294,756	)	$	53,971		$	77	$	54,048
Shares issued for Island pursuant to acquisition		8,783,716		6,245		—		—			6,245			—		6,245
Warrants issued for Island pursuant to acquisition		—		732		—		—			732			—		732
Share-based compensation		—		—		390		—			390			—		390
Shares issued with exercise of stock options		51,975		33		—		—			33			—		33
Net loss		—		—		—		(6,551	)		(6,551	)		5		(6,546	)
Balance, June 30, 2022		637,912,894	$	302,502	$	53,625	$	(301,307	)	$	54,820		$	82	$	54,902

See accompanying notes to condensed interim financial statements.

3

4FRONT VENTURES CORP.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (unaudited)

For the Six Months Ended June 30, 2022 and 2021

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

	Share Capital
	Shares			Amount		Additional Paid-In Capital		Deficit			Total 4Front Ventures Corp. Shareholders’ Equity			Non- Controlling Interest		Total Shareholders’ Equity
Balance, December 31, 2020		538,851,252		$	250,583	$	42,116	$	(250,548	)	$	42,151		$	52	$	42,203
Shares issued for Pure Ratios earnout		473,491			161		—		—			161			—		161
Share-based compensation		—			—		2,396		—			2,396			—		2,396
Conversion of notes to equity		24,366,003			6,253		—		—			6,253			—		6,253
Shares issued with exercise of stock options		1,358,116			871		—		—			871			—		871
Shares issued with exercise of warrants		2,422,363			1,563		—		—			1,563			—		1,563
Return of treasury shares		(8,320	)		—		—		—			—			—		—
Net loss		—			—		—		(11,089	)		(11,089	)		5		(11,084	)
Balance, March 31, 2021		567,462,905		$	259,431	$	44,512	$	(261,637	)	$	42,306		$	57	$	42,363
Shares issued for Om of Medicine earnout		535,018			722		—		—			722			—		722
Share-based compensation		—			—		2,979		—			2,979			—		2,979
Conversion of notes to equity		24,676,794			11,466		—		—			11,466			—		11,466
Shares issued with exercise of stock options		652,940			443		—		—			443			—		443
Shares issued with exercise of warrants		570,864			1,813		—		—			1,813			—		1,813
Net loss		—			—		—		(6,223	)		(6,223	)		5		(6,218	)
Balance, June 30, 2021		593,898,521		$	273,875	$	47,491	$	(267,860	)	$	53,506		$	62	$	53,568

See accompanying notes to condensed interim financial statements.

4

4FRONT VENTURES CORP.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (unaudited)

For the Six Months Ended June 30, 2022 and 2021

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

	Six Months Ended June 30,
	2022			2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(12,440	)	$	(17,302	)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization		4,689			2,166
Equity based compensation		1,428			5,375
Change in fair value of derivative liability		(3,074	)		2,843
Change in fair value of contingent consideration		(2,393	)		—
Amortization of right-of-use assets		—			1,765
Accretion of lease liability		2,803			(478	)
Write-off of fixed asset from terminated lease		—			1,210
Accretion of contingent consideration		—			228
Accretion of convertible debenture and interest		564			850
Accrued interest on notes payable		3,614			3,884
Interest accrued - lease receivable		432			349
Deferred taxes		(965	)		632
Amortization of loan discount upon conversion of debt to equity		—			2,915
Changes in operating assets and liabilities		2,458			(170	)
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES		(2,884	)		4,267
CASH FLOWS FROM INVESTING ACTIVITIES
Payment for NECC business combination, net of cash acquired		(24,998	)		—
Cash acquired as part of Island business combination		458			—
Notes receivable repayments		109			405
Sale of dispensaries and interests in cannabis licenses		—			1,093
Purchases of property and equipment		(2,249	)		(12,234	)
NET CASH USED IN INVESTING ACTIVITIES		(26,680	)		(10,736	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of contingent consideration		(412	)		(1,204	)
Proceeds from issuance of construction financing liability		16,000			—
Proceeds from the exercise of warrants		50			1,664
Proceeds from the exercise of stock options		33			1,314
Repayment of notes payable		(2,656	)		(2,674	)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES		13,015			(900	)
NET DECREASE IN CASH		(16,549	)		(7,369	)
CASH, BEGINNING OF QUARTER		22,581			18,932
CASH, END OF QUARTER	$	6,032		$	11,563

See accompanying notes to condensed interim financial statements.

5

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 1: NATURE OF OPERATIONS

4Front Ventures Corp. (“4Front” or the “Company”) exists pursuant to the provisions of the British Columbia Corporations Act. On July 31, 2019, 4Front Holdings LLC (“Holdings”) completed a Reverse Takeover Transaction (“RTO”) with Cannex Capital Holdings Inc. (“Cannex”) whereby Holdings acquired Cannex and the shareholders of Holdings became the controlling shareholders of the Company. Following the RTO, the Company’s SVS are listed on the Canadian Securities Exchange (“CSE”) under the ticker “FFNT” and are quoted on the OTC (OTCQX: FFNTF).

The Company has 2 primary operating segments: THC Cannabis and CBD Wellness. With regard to its THC Cannabis segment, as of June 30, 2022, the Company operates 6 dispensaries in Massachusetts, Illinois, and Michigan, primarily under the “MISSION” brand name. As of June 30, 2022, the Company operates 3

production facilities in Massachusetts, Illinois and California and produces the majority of products that are sold at its own Massachusetts and Illinois dispensaries. Also, as part of its THC Cannabis segment, the Company leases real estate and sells equipment, supplies, and intellectual property to cannabis producers in the state of Washington.

While marijuana is legal under the laws of several U.S. states (with varying restrictions), the United States Federal Controlled Substances Act classifies all “marijuana” as a Schedule 1 drug, whether for medical or recreational use. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision.

The Company’s CBD Wellness segment is focused upon its ownership and operation of its wholly owned subsidiary, Pure Ratios Holdings, Inc. (“Pure Ratios”), a

CBD-focused

wellness company in California, that sells

non-THC

hemp derived products throughout the United States.

On January 28, 2022, the Company entered into an agreement and plan of merger (the “NECC Merger Agreement”) with New England Cannabis Corporation, Inc., a Massachusetts Corporation (“NECC”) and a wholly owned subsidiary of the Company entered into an amended membership interest purchase agreement (the “Everett Purchase Agreement,” and together with the NECC Merger Agreement, the “NECC Merger Agreements”) with Kenneth Stevens to purchase all of the membership interests of 29 Everett, LLC (“29 Everett”), a Massachusetts limited liability company. See Note 7 for further details on the NECC Merger Agreements and corresponding transactions under such agreements.

On March 30, 2022, the Company entered into an agreement and plan of merger (the “Island Merger Agreement”) by and among the Company, Island Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Island Merger Sub”); Island Global Holdings, Inc., a California corporation (“Island”); and Navy Capital SR LLC, a Delaware limited liability company (“Navy”, and together with the Company, Island Merger Sub, and Island, the “Island Parties”). In April 2022, pursuant to the terms and conditions of the Merger Agreement, Island Merger Sub merged with and into Island, with Island surviving the merger and continuing its corporate existence as a wholly owned subsidiary of the Company (the “Island Merger”). See Note 7 for further details on the Island Merger Agreements and corresponding transactions under such agreements.

Management continues to evaluate the impact of the

COVID-19

pandemic on the Company’s industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of these consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The corporate office address of the Company is 5060 North 40th Street, Suite 120, Phoenix, Arizona, and the Company’s registered office is 550 Burrard Street, Suite 2900, Vancouver, British Columbia.

6

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 2: BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations.

In the opinion of management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2021, included in the Company’s Annual Report on Form

10-K,

filed April 18, 2022, with the U.S. Securities and Exchange Commission, as well as the Company’s Amendment to the Annual Report on Form

10-K,

filed April 21, 2022, and on the System for Electronic Document Analysis and Retrieval in Canada (or SEDAR). The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

There have been no changes to the Company’s significant accounting policies as described in Note 2 of the Company’s 2021 Annual Report on Form

10-K.

The Company’s accounting policies have remained consistent with those disclosed in the latest annual consolidated financial statements except for the additional policy noted below.

Principles of consolidation

The accompanying condensed consolidated interim financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. The financial results of NECC are included in the condensed consolidated financial statements beginning on January 28, 2022, the merger closing date. The financial results of Island are included in the condensed consolidated financial statements beginning on April 25, 2022, the merger closing date.

The financial statements of the subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies.

Note 3: SIGNIFICANT ACCOUNTING POLICIES

(a) Critical accounting estimates and judgments

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of the Company’s condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods. The significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those described in the latest annual consolidated financial statements, except for additional accounting policies identified during the interim period noted below.

7

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Contract Assets and Liabilities

To the extent that the customer has paid consideration before transferring goods or services to the customer, a contract liability is recorded on the consolidated balance sheet as current portion of contract liabilities for contract liabilities due within twelve months or contract liabilities for contract liabilities due after twelve months. When the Company has an unconditional right to payment, a receivable is recorded on the consolidated balance sheet as current portion of contract assets for contract assets due within twelve months or contract assets for contract assets due after twelve months. Amounts expected to be recognized as revenue within the twelve months following the balance sheet date are classified as current portion of contract liabilities in the accompanying condensed balance sheets. Amounts not expected to be recognized as revenue within the twelve months following the balance sheet date are classified as contract liabilities. The accompanying condensed balance sheets reflect a contract liability for the amount of revenue to be recognized in the future as and when the Company satisfies its remaining performance obligations. As of June 30, 2022, in connection with the Island Merger, the Company had recogn

ized $

3,535

of contract liabilities, $

1,535

of which were recorded as current liabilities and $

2,000

were recorded as long term liabilities. See Note 7 for further discussion on the Island Merger.

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

(b) Recent Accounting Pronouncements

Recently Adopted

i. In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)”. ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Adoption of this standard did not materially impact the Company’s consolidated financial position, results of operations or cash flows.

ii. In May 2021, the FASB issued ASU 2021-04, “Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (Subtopic 815-40)”. ASU 2021-04 clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. ASU 2021-04 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Adoption of this standard did not materially impact the Company’s consolidated financial position, results of operations or cash flows.

iii. In October 2021, the FASB issued ASU 2021-08, “Business Combinations—Accounting for Contract Assets and Contract Liabilities (Topic 805)”. The amendments in this update address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination by requiring that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. As a result of the amendments made by the ASU, it is expected than an acquirer will generally recognize and measure acquired contract assets and contract liabilities in a manner consistent with how the acquiree recognized and measured them in its pre-acquisition financial statements. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. An entity that early adopts in an interim period should apply the amendments (i) retrospectively to all business combinations for which the acquisition date occurs on or after the beginning of the fiscal year that includes the interim period of early application and (ii) prospectively to all business combinations that occur on or after the date of initial application. The Company has elected to early adopt this standard as of January 1, 2022. The adoption of the standard had an impact on the valuation of Island deferred revenue contracts upon the acquisition date. The Company recognized the contract liabilities acquired consistent with the previous accounting treatment at the acquired entity. This standard did not have an impact on the NECC acquisition entered into on January 28, 2022.

8

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Accounting Pronouncements Not Yet Adopted

i. In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurements—Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (Topic 820)”. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. It also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. For public business entities, the ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted and the amendments in the ASU should be applied prospectively with any adjustments from the adoption of the amendments recognized in earnings and disclosed on the date of adoption. The Company is currently assessing the impact of adopting ASU 2022-03 on the consolidated financial statements.

Note 4: INVENTORY

The Company’s inventories include the following as of June 30, 2022 and December 31, 2021:

	June 30, 2022		December 31, 2021
Raw materials - unharvested cannabis	$	2,849	$	2,164
Raw materials - harvested and purchased cannabis		10,824		3,045
Packaging and other non-finished goods		2,986		1,734
Work in process - manufactured and purchased extracts		4,825		4,771
Finished goods		7,353		8,373
Total	$	28,837	$	20,087

Note 5: PROPERTY, PLANT, AND EQUIPMENT

Property, plant and equipment and related depreciation are summarized in the table below:

	June 30, 2022			December 31, 2021
Land	$	775		$	—
Buildings & improvements		13,896			1,483
Construction in process		702			63
Furniture, equipment & other		17,974			13,425
Leasehold improvements		36,878			35,538
Total	$	70,225		$	50,509
Less: accumulated depreciation		(11,258	)		(7,876	)
Total property, plant, and equipment, net	$	58,967		$	42,633

On January 28, 2022, in conjunction with a business combination with NECC, the Company acquired property, plant, and equipment totaling $15,238 (Note 7). The Company subsequently sold the property, plant, and equipment to a third-party and leased back the equipment from the third-party. As discussed in Note 9, the Company recognized this fact pattern as a failed sale-leaseback transaction, whereby the Company recognized the fixed assets on the balance sheet of NECC and established a construction finance liability for rental payments made as part of the lease agreement.

On April 25, 2022, in conjunction with a business combination with Island, the Company acquired property and equipment totaling $2,214. (Note 7).

Approximately $33,000 of property and equipment is secured by LI Lending as collateral on the LI Lending note (Note 9). There were 0 significant contractual commitments for future capital expenditures as of June 30, 2022 and December 31, 2021.

Depreciation of property, plant, and equipment is computed using the

 straight-line method over the asset’s estimated useful life. The Company does not depreciate land, which has an indefinite useful life. Depreciation expense for the six months ended June 30, 2022 and 2021 was $3,382 and $1,138, respectively, of which $2,719 and $725, respectively, is included in cost of goods sold. Depreciation expense for the three months ended June 30, 2022 and 2021 was $2,217 and $675, respectively, of which $1,771 and $400, respectively, is included in cost of goods sold.

9

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 6: INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

Intangible assets are recorded at cost less accumulated amortization and impairment losses. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is recognized on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

Intangible assets and related amortization are summarized in the table below:

	Licenses		Customer Relationships			Non-Competition Agreements			Know-How			Tradenames and Trademarks			Total
Balance, December 31, 2020	$	20,146	$	1,668		$	43		$	6,933		$	—		$	28,790
Amortization expense		—		(580	)		(43	)		(1,921	)		—			(2,544	)
Balance, December 31, 2021	$	20,146	$	1,088		$	—		$	5,012		$	—		$	26,246
NECC merger and 29 Everett acquisition (Note 7)		18,000		—			—			—			—			18,000
Island merger (Note 7)		8,700		—			—			—			2,600			11,300
Amortization expense		—		(290	)					(970	)		(47	)		(1,307	)
Balance, June 30, 2022	$	46,846	$	798		$	—		$	4,042		$	2,553		$	54,239

Goodwill

Balance, December 31, 2020	$	23,155
Balance, December 31, 2021	$	23,155
NECC merger and 29 Everett acquisition (Note 7)		12,547
Island merger (Note 7)		6,335
Balance, June 30, 2022	$	42,037

Impairment of Intangible Assets and Goodwill

On an annual basis, the Company assesses the Company’s reporting units (“RUs”) for indicators of impairment or when facts or circumstances suggest that it is more likely than not that the carrying amount may exceed fair value. For the purpose of impairment testing, goodwill is allocated to the Company’s RUs to which it relates.

Goodwill was 0t tested for impairment during the six months ended June 30, 2022.

Six Months Ended June 30, 2022

On January 28, 2022, the Company entered into the NECC Merger Agreements with NECC and 29 Everett for total consideration of $45,200. As part of the purchase price allocation of the acquisition and merger, the Company recognized $18,000 of acquired licenses and $12,547 of goodwill based on the consideration transferred and fair value of

net

assets acquired.

On April 25, 2022, the Company entered into the Island Merger Agreement with Island for total consideration of $16,977. As part of the purchase price allocation of the acquisition and merger, the Company recognized $8,700 of acquired licenses, $2,600 of trade names and trademarks and $6,335 of goodwill based on the consideration transferred and fair value of

net

assets acquired.

For further details on the acquisitions and purchase price allocations, see Note 7.

Year Ended December 31, 2021

In 2021, management assessed indicators of impairment and concluded the below for the respective RUs:

Retail, Production and Ancillary Cannabis Reporting Units

Management did not identify any significant negative triggering events that would suggest it is more likely than not that impairment exists. Therefore, further analysis was not required for these RUs.

10

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Pure Ratios RU

As of June 30, 2022 and December 31, 2021, the accumulated impairment is $13,400, which is due to goodwill impairment of the entire outstanding balance of goodwill on the Pure Ratios segment for the year ended December 31, 2020. As a result, the segment does not have a balance of goodwill or intangible assets remaining as of December 31, 2021.

Note 7: ACQUISITIONS AND BUSINESS COMBINATIONS

NECC Merger Agreement

On January 28, 2022, the Company entered into the merger agreement (the “NECC Merger”) with NECC, Kenneth V. Stevens (“Mr. Stevens”), who is the sole owner of all of the issued and outstanding capital stock of NECC, and 4Front NECC Acquisition Co., a Massachusetts corporation (the “NECC Merger Sub”). At the effective time of the merger, the Company (i) paid Mr. Stevens cash in the amount of $9,000,000, and (ii) issued Mr. Stevens 28,571,428 Class A Subordinate Voting shares of the Company (the “SVS”).

In connection with the consummation of the NECC Merger on January 28, 2022, Mission Partners RE, LLC, a Delaware limited liability company wholly owned by the Company (“Mission Partners RE”), and Mr. Stevens entered into the first amendment to that certain membership interest purchase agreement (the “Everett Purchase Agreement”). Pursuant to the Everett Purchase Agreement, the Company (through Mission Partners RE) completed its acquisition of 100% of the issued and outstanding membership interests of 29 Everett Street LLC, a Massachusetts limited liability company (the “Everett LLC”), which was solely held by Mr. Stevens and which owns certain real property that is currently leased to and used by NECC. The Company (i) paid Mr. Stevens cash in the amount of $16,000,000, and (ii) issued Mr. Stevens a promissory note in the initial principal amount of $2,000,000, which will bear interest at an annual rate of ten percent (10%) and mature

d

on the

six-month

anniversary of January 28, 2022.

On July 28, 2022, the parties amended the promissory note to provide for payment of half the principal on the initial maturity date, and the remaining principal and all accrued interest on September 12, 2022. The Merger and Purchase Agreement were recorded as one transaction (collectively, referred to as the “NECC Acquisitions”), as the entities were commonly owned by the same individual and the purchase of Everett LLC was contingent on the Merger with NECC.

The NECC Merger was accounted for as a business combination in accordance with ASC 805. The Company has determined preliminary fair values of the assets acquired and liabilities assumed in the NECC Merger. These values are subject to change as the Company completes its determination of the fair value of assets acquired and liabilities assumed. Upon acquisition of NECC and Everett LLC on January 28, 2022, the Company consolidated the operations of Everett LLC into NECC. As of the date of acquisition, the Company recognized NECC under the THC Cannabis segment as part of segment reporting.

The Company entered into the NECC Merger in order to acquire cannabis licenses, as well as property and equipment held by NECC to increase the Company’s presence in Massachusetts and the northeastern United States. As part of the NECC, the Company incurred $130 in restructuring costs, which were included in transaction and restructuring related expenses and expensed as incurred. As part of the NECC Merger, the Company incurred $544 in transaction costs, which were included in transaction and restructuring related expenses and expensed as incurred.

11

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

The following tables present the preliminary purchase price allocation for the NECC Merger:

Cash consideration	$	25,000
Seller note		2,000
Equity consideration - common stock		18,200
Total Purchase Price	$	45,200

Description	Fair value
Assets acquired:
Cash	$	2
Inventory		213
Property, plant, and equipment		15,238
Intangible asset - licenses		18,000
Total assets acquired	$	33,453
Liabilities assumed:
Accounts payable		800
Total liabilities assumed	$	800
Estimated fair value of net assets acquired	$	32,653
Estimated Goodwill	$	12,547

Goodwill and Intangible Assets

Goodwill is represented by the future potential for the generation of positive cash flows and future relationships associated with the Company’s operations. While NECC had yet to generate revenues as of the date of the Merger, the Company identified that the inputs of the business were in place to begin generating revenue during fiscal year 2022. The Company adjusts provisional goodwill balance when new information is obtained regarding the valuation of acquired assets and liabilities during a

one-year

measurement period from the date of acquisition in accordance with ASC

805-10.

The Company has determined that the goodwill recognized in the above acquisition is not deductible for tax purposes.

The intangible assets acquired by the Company consist of cannabis licenses for operations. Utilizing alike licenses as a benchmark, the Company determined that the licenses acquired are indefinite lived assets.

Island Merger Agreement

On March 30, 2022, the Company entered into an agreement and plan of merger (the “Island Merger Agreement”) by and among the Company, Island Merger Sub, Island, and Navy (together the “Island Parties”). Pursuant to the terms and conditions of the Merger Agreement, Island Merger Sub merged with and into Island, with Island surviving the merger and continuing its corporate existence as a wholly owned subsidiary of the Company (the “Island Merger”). The Island Merger Agreement was to be effective as of April 25, 2022 (the “Effective Date”).

12

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

On the Effective Date, the Island Parties consummated the Island Merger, pursuant to the terms and conditions of the Island Merger Agreement, as amended. However, due to administrative and technical issues at the California Office of the Secretary of State, the Island Parties did not receive the certificate of merger evidencing the closing of the Island Merger as of the Effective Date until April 25, 2022. At the Effective Date, pursuant to the terms and conditions of the Island Merger Agreement, as amended, the Company issued to certain shareholders and debtholders of Island an aggregate of: (i) 8,783,716 Class A Subordinated Voting Shares of the Company (the “SVS”); (ii) 6%

54-month,

subordinated promissory notes (the “Island Merger Notes”) in the aggregate principal amount of $6,500,000; and (iii) warrants to purchase 2,999,975 SVS at a price of $1.00 per SVS (the “Warrants”, and together with the SVS and Island Merger Notes, the “Island Merger Consideration”).

On April 22, 2022, the Parties entered into the first amendment to the Island Merger Agreement to replace the requirement that certain noteholders fund a letter of credit to Island of up to $1,000,000. In lieu of funding a

letter

 of credit, the noteholders agreed to pay the full $1,000,000 in cash to Island on or prior to the closing of the transactions contemplated by the Island Merger Agreement.

The Island Merger was accounted for as a business combination in accordance with ASC 805. The Company has determined preliminary fair values of the assets acquired and liabilities assumed in the Island Merger. These values are subject to change as the Company completes its determination of the fair value of assets acquired and liabilities assumed. Upon acquisition of Island and Navy on April 25, 2022, the Company consolidated the operations of Navy into Island. As of the date of acquisition, the Company recognized Island under the THC Cannabis segment as part of segment reporting.

The Company entered into the Island Merger in order to add new high-quality products to the Company’s growing brand portfolio, including diverse lines of

pre-rolls,

flower and infused products, as well as reduce production costs. As part of the Island Merger, the Company incurred

$

1,288 in restructuring costs, which were included in transaction and restructuring related expenses and expensed as incurred. As part of the Island Merger, the Company incurred $47 in transaction costs, which were included in transaction and restructuring related expenses and expensed as incurred.

The following tables present the preliminary purchase price allocation for the Island Merger:

Seller note	$	10,000
Equity consideration - common stock		6,245
Equity consideration - warrants		732
Total Purchase Price	$	16,977

Description	Fair value
Assets acquired:
Cash	$	458
Accounts receivable		876
Inventory		3,072
Prepaid expenses and other current assets		424
Property and equipment, net		2,214
Operating lease - right of use asset		10,227
Intangible assets		11,300
Total assets acquired	$	28,571
Liabilities assumed:
Accounts payable	$	1,356
Accrued expenses and other liabilities		2,566
Contract liabilities		3,535
Lease liabilities		10,227
Notes payable		245
Total liabilities assumed	$	17,929
Estimated fair value of net assets acquired	$	10,642
Estimated Goodwill	$	6,335

13

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Goodwill and Intangible Assets

Goodwill is represented by the future potential for the generation of positive cash flows and future relationships associated with the Company’s operations. The Company adjusts provisional goodwill balance when new information is obtained regarding the valuation of acquired assets and liabilities during a

one-year

measurement period from the date of acquisition in accordance with ASC

805-10.

The Company has determined that the goodwill recognized in the above acquisition is not deductible for tax purposes.

The intangible assets acquired by the Company consist of cannabis licenses

,

trade names and trademarks for operations. Utilizing alike licenses as a benchmark, the Company determined that the licenses acquired are indefinite lived assets and the trade names and trademarks have a life of ten years.

Unaudited Pro Forma Results

The following unaudited pro forma financial information presents the results of operations of the Company, NECC, and Island for the six months ended June 30, 2022 and 2021, as if the acquisitions had occurred as of the beginning of the first period presented instead of on January 28 and April 25, 2022, respectively. The pro forma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during those periods.

The unaudited pro forma financial information for the Company including NECC and Island for the three months ended June 30, 2022 is as follows:

	For the For the Three Months Ended June 30,
	2022						2021
	Reported			Proforma			Reported			Proforma
Revenues	$	28,439		$	28,706		$	27,121		$	28,922
(Loss) income from operations		(4,099	)		(5,444	)		668			(936	)
Net loss	$	(6,546	)	$	(8,932	)	$	(6,218	)	$	(8,115	)
Basic and diluted earning (loss) per share	$	(0.01	)	$	(0.01	)	$	(0.01	)	$	(0.01	)

The unaudited pro forma financial information for the Company including NECC and Island for the six months ended June 30, 2022 is as follows:

	For the For the Six Months Ended June 30,
	2022						2021
	Reported			Proforma			Reported			Proforma
Revenues	$	54,487		$	56,113		$	50,091		$	53,286
(Loss) income from operations		(5,340	)		(9,399	)		1,021			(2,490	)
Net loss	$	(12,440	)	$	(20,817	)	$	(17,302	)	$	(20,813	)
Basic and diluted earning (loss) per share	$	(0.02	)	$	(0.03	)	$	(0.02	)	$	(0.04	)

Note 8: LEASES

The Company has operating leases for its facilities where the Company conducts its operations. These leases have remaining lease terms ranging from 1 year to 19.2 years.

All real estate leases are recorded on the balance sheet. Equipment and other

non-real

estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Many leases include one or more options to renew the lease at the end of the initial term. The Company considered renewals in its

right-of-use

assets and operating lease liabilities. Certain real estate leases require payment for taxes, insurance and maintenance which are considered

non-lease

components. The Company accounts for real estate leases and the related fixed

non-lease

components together as a single component.

The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract.

There are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space.

14

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

The Company’s lease agreements occasionally provide an implicit borrowing rate. When implicit borrowing rates are provided, the Company utilizes these implicit borrowing rates to calculate

right-of-use

assets and liabilities at the end of each reporting period. The Company may enter into leases that do not provide an implicit borrowing rate. When an implicit borrowing rate is not provided, the Company uses a benchmark approach to derive an appropriate imputed discount rate. The Company will benchmark itself against other companies of similar credit ratings and compare quality and derive an imputed rate, which was used in a portfolio approach to discount its lease liabilities.

For the three months ended June 30, 2022 and 2021 the Company recorded $2,595 and $2,400 in operating lease expense, respectively. For the six months ended six months ended June 30, 2022 and 2021 the Company recorded $7,417 and $4,868 in operating lease expense, respectively.

(a) The Company as a Lessee

The following table summarizes the Company’s operating leases:

	Classification - Consolidated Balance Sheet	June 30, 2022		December 31, 2021
Assets
Operating lease assets	Operating Lease Assets	$	106,406	$	100,519
Liabilities
Current
Operating	Current portion of operating lease liabilities		4,121		3,629
Noncurrent
Operating	Operating lease liabilities		101,380		93,111
Total lease liabilities		$	105,501	$	96,740

The components of lease expense are included in cost of goods sold, general and administrative expenses, and selling and marketing expenses, based on the underlying use of the

right-of-use

asset.

Maturities of lease liabilities for third-party operating leases as of June 30, 2022 were as follows:

	Operating Leases
2022	$	8,329
2023		16,987
2024		17,491
2025		17,633
2026		18,056
2027		18,076
2028 and Thereafter		234,359
Total undiscounted cash flows	$	330,931
Less discounting		(225,430	)
Total lease payments	$	105,501

The Company has

right-of-use

assets and lease liabilities for leased real estate for dispensaries, cultivation and production facilities and office space. The incremental borrowing rate used for leases for 2022 was 10.25 - 18% and was 10.25 - 17% for 2021.

15

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

(b) The Company as a Lessor:

The Company leases a building in Elma, Washington that is subleased by the Company to a third party. This sublease is classified as a finance lease with a long term lease receivable balance of $6,541 and a short term lease receivable balance of $3,405 as of June 30, 2022 compared to a long term lease receivable balance of $6,748 and a short term lease receivable balance of $3,630 as of December 31, 2021. This lease generated $676 of the $2,951 and $570 of the $2,669 in real estate income for the three months ended June 30, 2022 and 2021, respectively. This lease generated $1,368 of the $5,916 and $1,361 of the $5,559 in real estate income for the six months ended June 30, 2022 and 2021, respectively.

The Company owned buildings in Olympia, Washington that were leased to a third party. This lease was classified as a finance lease. On December 17, 2020, the Company sold the Olympia building and other assets as part of a sale and leaseback transaction and this lease was cancelled. The Company applied ASC 842 to a new sublease to the same third party and classified the new sublease as an operating lease. The lease receivable was sold to the purchaser of the assets as part of the sale and leaseback transaction. This lease generated $2,275 of the $2,951 and $2,099 of the $2,669 in real estate income for the three months ended June 30, 2022 and 2021, respectively. This lease generated $4,548 of the $5,916 and $4,198 of the $5,559 in real estate income for the six months ended June 30, 2022 and 2021, respectively.

The following table summarizes changes in the Company’s lease receivables:

	June 30, 2022			December 31, 2021
Balance, beginning of the year	$	10,378		$	11,045
Interest		1,368			2,783
Lease payments received		(1,800	)		(3,450	)
Balance, end of the period	$	9,946		$	10,378
Less current portion		(3,405	)		(3,630	)
Long-term lease receivables	$	6,541		$	6,748

Future minimum lease payments receivable (principal and interest) on the leases are as follows:

	Operating Leases
2022	$	1,830
2023		1,575
2024		0—
2025		0—
2026		0—
Thereafter		0—
Total minimum lease payments		3,405
Effect of discounting		(431	)
Present value of minimum lease payments		2,974
Present value of residual value of leased property		6,972
Total lease receivable		9,946
Current portion lease receivable		(3,405	)
Long-term lease receivable	$	6,541

16

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 9: NOTES PAYABLE AND CONVERTIBLE NOTES

The Company’s notes payable and convertible notes are as follows:

	LI Lending, LLC			May 2020 Convertible Notes			2022 Island Global Holdings Related Party Notes		May 2020 Convertible Notes (Swap)			October 2021 Convertible Note		Other Loans			Total
Balance, December 31, 2020	$	45,362		$	2,855		$	—	$	11,867		$	—	$	6,931		$	67,015
Loans advanced, net		—			—			—		—			14,376		930			15,306
Loan payments		(4,671	)		—			—		—			—		(1,079	)		(5,750	)
Converted to equity		—			(5,852	)		—		(11,867	)		—		—			(17,719	)
Accrued interest		7,575			2,997			—		—			265		1,124			11,961
Balance, December 31, 2021	$	48,266		$	—		$	—	$	—		$	14,641	$	7,906		$	70,813
Loans advanced, net		—			—			245		—			—		13,138			13,383
Loan payments		(2,526	)		—			—		—			—		(130	)		(2,656	)
Converted to equity		—			—			—		—			—		(2,784	)		(2,784	)
Accrued interest		3,381			—			—		—			564		233			4,178
Balance, June 30, 2022	$	49,121		$	—		$	245	$	—		$	15,205	$	18,363		$	82,934
Less current portion		—			—			—		—			—		(8,235	)		(8,235	)
Long-term portion	$	49,121		$	—		$	245	$	—		$	15,205	$	10,128		$	74,699

Convertible Notes

On May 14, 2020, the Company issued $5,827 in convertible notes to existing investors in the Company. The notes pay interest of 5% per annum and have a maturity date of February 28, 2022. The notes can be converted into SVS of the Company for $0.25 per share at any time at the option of the holder.

The Company was permitted to require

 mandatory conversion at any time that the Company’s stock price remains above $0.50 for 45 consecutive days. In 2021, the Company enacted the mandatory conversion feature and converted the May 2020 Convertible Note balance to subordinate voting shares.

As part of issuing the convertible notes, the investors were given the right to exchange stock in the Company into separate convertible notes (swap notes). In total 29,448,468 shares with a value of $13,661 were exchanged for $13,661 in convertible notes. These notes were effective May 28, 2020, have a maturity date of May 28, 2025, and can be converted into Class A Subordinate Voting Shares of the Company for $0.46 per share at any time at the option of the holder. The notes pay no interest if the Company’s annual revenue is greater than $15,000, and 3% annually otherwise. The Company can require mandatory conversion at any time that the Company’s stock price remains above $0.92 for 45 consecutive days. In 2021, the Company exercised the mandatory conversion feature and converted the May 2020 Convertible Note (Swap) balance to subordinate voting shares.

On October 6, 2021, the Company entered into a convertible promissory note purchase agreement for $15,000, less issuance costs of $624, resulting in net proceeds of $14,376. The notes pay interest of 6% per annum and have a maturity date of October 6, 2024. The notes can be converted into SVS of the Company for $1.03 per share at any time at the option of the holder. As of June 30, 2022, 0 payments have been made for this loan.

LI Lending LLC

On May 10, 2019, the Company entered into a loan agreement with LI Lending LLC, a related party, for $50,000. LI Lending LLC is related because an officer of the Company is a part-owner of LI Lending LLC. As of June 30, 2022, the Company had drawn $45,000 on the loan in two amounts, an initial $35,000 and a final $10,000, both bearing a 10.25% and 12.25% interest rate, respectively. The outstanding balance as of June 30, 2022 is $49,457, less debt discount of $336, for a net balance of $49,121. See Note 13 for further discussion of this related party transaction.

In April 2020, the loan was amended. In exchange for consent to allow the sale of the Pennsylvania and Maryland assets and the release of related collateral, the Company agreed to make prepayments of principal to LI Lending LLC in the amount of $250 per month for an eight-month period beginning on May 1, 2020. The $2,000 prepayment was applied to the initial $35,000 amount, decreasing the balance to $33,000. Additionally, the Company agreed to pay an increased interest rate of 12.25% on the final $10,000 of the loan until such time as this amount has been paid down, with the initial $33,000 amount continuing to be subject to the original 10.25% interest rate.

In December 2020, the loan was amended to allow for the release of collateral for the sale and leaseback transactions described in Note 8 above, which was entered into with Innovative Industrial Properties, Inc. (“IIPR”). The amendment increased both interest rates by 2.5% on the loan amounts but allowed the payments resulting from the incremental interest to be deferred until January 1, 2022. The Company elected to defer payment, and the additional 2.5% interest is accrued each month and added to the balance of the loan. The Company was required to make interest-only payments monthly of 10.25% on the initial $33,000 and 12.25% on the final $10,000 of the loan until January 1, 2022 when the interest rates of 12.75% for the initial $33,000 and 14.75% for the final $10,000 took effect for the remaining term.

The loan matures on May 10, 2024. An exit fee of 20% of the principal balance will be due as principal is repaid. Accrued interest expense of $3,381 includes a loan discount accretion expense of $165 for the six months ended June 30, 2022. Accrued interest expense of $1,490 includes a loan discount accretion expense of $40 for the three months ended June 30, 2022. On January 1, 2022, the Company began making the required principal payments in addition to the interest payments for this loan. As of June 30, 2022, the Company has made $2,526 in payments on this loan.

17

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Other

Outstanding as of June 30, 2022 were other payables totaling $18,363 which include notes issued as part of the acquisitions of Healthy Pharms, NECC, and Arkansas entities as follows:

Other

Subsidiary	Terms	June 30, 2022		December 31, 2021
Healthy Pharms Inc.	Unsecured convertible note, due November 18 , 2021 at 12% per annum	$	—	$	2,784
Healthy Pharms Inc.	Unsecured promissory note at $0.50 per share due December 18, 2022 at 10% per annum (1)		3,377		3,213
Island Global	Promissory note due October 25, 2026 at 6% per annum		10,128		—
NECC	Promissory note due September 12, 2022 at 10% per annum		2,084		—
Om of Medicine, LLC	Promissory note due September 1, 2022 at 12% per annum (3)		981		—
Arkansas Entities	Unsecured Promissory note due December 1, 2022, monthly interest payments at 14% per annum		1,709		1,709
Equipment Loans	Secured by equipment, monthly payments beginning in 2021 at 15% per annum		63		49
Other	Various		21		151
Total Notes Payable and Convertible Notes		$	18,363	$	7,906

(1) In November 2021, the unsecured promissory note was modified to be due and payable in full on or before December 18, 2022. The Company concluded the extension resulted in a debt modification under ASC 470 .

(2) In July 2022, the promissory note was modified, whereby 50% of the outstanding note payable was paid on July 28, 2022, and the remaining outstanding balance of the note was to be payable in full on or before September 12, 2022.

(3) In April 2022, the Company entered into a seller note payable to pay the outstanding balance due resulting from the 2021 Om earnout in connection with prior period contingent considerations. The note bore 10% interest per annum and was due to be paid in full by July 1, 2022. At the time of the issuance of the note, the liability was current and was certain to be paid during 2022. In July 2022, the Company amended the note, whereby the Company paid $345 of the remaining balance on the seller note and the term of the remaining balance of the seller note was extended to September 1, 2022, bearing interest at 12% per annum. If payment is not received in full by September 1, 2022, the remaining balance on the note will accrue interest at 20% per annum until payment is made in full. See Note 14 for further details on contingent considerations and the Om earnout.

Future minimum payments on the notes payable and convertible debt are as follows:

	June 30, 2022
2022	$	8,235
2023		—
2024		64,326
2025		—
2026		12,874
Thereafter		—
Total minimum payments		85,435
Effect of discounting		(2,501	)
Present value of minimum payments		82,934
Less current portion		(8,235	)
Long-term portion	$	74,699

Construction Finance Liability

On January 28, 2022, a wholly owned subsidiary of the Company acquired property at 29 Everett in conjunction with the NECC Merger (see Note 7 for further details on the transaction). Concurrently, effective January 28, 2022, the Company sold a portion of the property it had acquired in the acquisition for

$16,000

.

In connection with the sale of the property at 29 Everett, the Company agreed to lease the location back for cultivation, effective on January 28, 2022. The details of the lease included three purchase options that the Company can exercise, in which the Company has the ability to repurchase the property on either the second, fourth, or sixth anniversary of the lease agreement. The Company determined that the purchase and subsequent leasing of the land, building, and equipment at NECC was a sale of real estate, as the property and equipment sold as part of the building were interrelated with the building. Under

ASC 842 - Leases

, lease arrangements where assets are sold and leased back, whereby the transaction fails to meet the definition of a sale of an asset, does not meet the definition of a sale because control is never transferred to the buyer-lessor. The transaction did not meet the sale-and-lease back criteria under ASC 842, and the transaction was treated as a failed sale-leaseback financing arrangement. On January 28, 2022, the Company recorded a construction finance liability for the proceeds received from the sale to recognize a liability resulting from the failed sale-leaseback transaction.

The initial term of the agreement is 20 years, with two options to extend the term for five years each. The initial monthly rent payment is equal to $140 for the first year of the agreement, with 3% annual increases over the life of the agreement. As of June 30, 2022, the total finance liability associated with this transaction is $16,000

. The total interest expense incurred during the six months ended June 30, 2022 was $700.

18

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 10: SHARE CAPITAL AND EQUITY

The Company has authorized an unlimited number of Class A Subordinate Voting Shares (“SVS”) and Class C Multiple Voting Shares (“MVS”), all with no par value. In December 2020, the shareholders of the Company passed a resolution to permit the Company to convert all Class B Subordinate Voting Shares (“PVS”) shares into Class A shares and cancel the Class B PVS equity class, which occurred in 2020.

All share classes are included within share capital in the consolidated statements of stockholders’ equity on an

as-

converted basis. Each share class is entitled to notice of and to attend at any meeting of the shareholders, except a meeting of which only holders of another particular class of shares will have the right to vote. All share classes are entitled to receive dividends, as and when declared by the Company, on an

as-converted

basis, and no dividends will be declared by the Company on any individual class unless the Company simultaneously declares or pays dividends on all share classes. No subdivision or consolidation of any share class shall be made without simultaneously subdividing or consolidating all share classes in the same manner.

Voting shares activity for the periods presented is summarized as follows:

	Class A Subordinate Voting Shares		Class C Multiple Voting Shares		Total
Balance, December 31, 2020		537,575,044		1,276,208		538,851,252
Share capital issuances		55,330,352		—		55,330,352
Balance, December 31, 2021		592,905,396		1,276,208		594,181,604
Share capital issuances		43,731,290		—		43,731,290
Balance, June 30, 2022		636,636,686		1,276,208		637,912,894

Class A Subordinate Voting Shares

Holders of Class A Subordinate Voting Shares are entitled to one vote in respect of each SVS.

Class C Multiple Voting Shares

Holders of Class C Multiple Voting Shares are entitled to 800 votes in respect of each MVS. One MVS can convert to one SVS but are not convertible until the later of the date that (i) the aggregate number of PVS and MVS held by the Initial Holders (being the MVS holders on their initial issuance) are reduced to a number which is less than 50% of the aggregate number of PVS and MVS held by the Initial Holders on the date of completion of the Business Combination with Cannex, and (ii) 3 years following the date of the business combination with Cannex.

Series	Shares outstanding as of June 30, 2022		As converted to SVS Shares
Class A - Subordinate Voting Shares		636,636,686		636,636,686
Class C - Multiple Voting Shares		1,276,208		1,276,208
		637,912,894		637,912,894

On November 23, 2020, the Company closed a brokered private placement and issued 24,644,500 Units at a price of C$0.70 per Unit. Each Unit is comprised of one subordinate voting share of the Company and

one-half

of a subordinate voting share purchase warrant. Each whole warrant entitles the holder to purchase one subordinate voting share for a period of two years from the date of issuance at an exercise price of C$0.90 per subordinate voting share. Net proceeds from this transaction were $11,557 net of share issuance costs of $690.

19

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Because of the Canadian dollar denominated exercise price, these warrants do not qualify to be classified within equity and are therefore classified as derivative liabilities at fair value with changes being reported through the statement of operations. On November 23, 2020, the warrants were valued using the Black Scholes option pricing model at $4,229 using the following assumptions: Share Price: C$0.94; Exercise Price: C$0.90; Expected Life: 2 years; Annualized Volatility: 87.73%; Dividend yield: 0.00%; Discount Rate: 0.16%; C$ Exchange Rate:1.31.

On June 30, 2022, the warrants were revalued using the Black Scholes option pricing model, using the following assumptions: Share Price: C$0.71; Expected Life: 0.4 years; Annualized Volatility: 61.40%; Dividend yield: 0.00%; Discount Rate: 2.51%; C$ Exchange Rate: 1.29. The decrease in the value of the derivative liability of $3,074 is reflected in the statement of operations as a $3,074 gain on the change in fair value of the derivative liability.

Note 11: WARRANTS

As of June 30, 2022, there were share purchase warrants outstanding to purchase up to 29,103,553 SVS shares:

Series	Number of warrants			Weight-average exercise price
Balance, December 31, 2021		26,192,237		$	0.75
Issued		2,999,975			1.00
Exercised		(88,659	)		0.56
Balance, June 30, 2022		29,103,553		$	0.75

As of June 30, 2022, the Company has the following warrants outstanding:

Warrants Outstanding	Exercise Price			Expiry Date
10,403,150	C$	0.90	*		November 23, 2022
209,426	C$	0.70	*		November 23, 2022
12,135,922	$	0.82	*		December 17, 2022
2,230,080	$	0.67	*		January 29, 2023
2,999,975	$	1.00			April 13, 2024
625,000	C$	0.80	*		October 6, 2024
500,000	C$	0.80	*		October 6, 2025
29,103,553

* Represents warrants that are exercisable as of June 30, 2022.

20

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 12: SHARE-BASED COMPENSATION

The Company adopted two equity incentive plans where the Company may grant Class A stock options. Under the terms of the plans, the maximum number of stock options which may be granted are a total of 10% of the number of shares outstanding assuming conversion of all shares to SVS. The exercise price for stock options issued under the plans will be set by the compensation committee of the board of directors but will not be less than 100% of the fair market value of the Company’s shares on the grant date. Stock options have a maximum term of 10 years from the date of grant. Stock options vest at the discretion of the Board.

As of June 30, 2022, the Company had the following options outstanding and exercisable on an

as-converted

basis:

Grant Date	Strike Price in CAD$		Outstanding Options		Exercisable Options		Life Remaining (years)
July 31, 2019		0.10		6,245,840		6,245,840		2.22
July 31, 2019		1.00		7,783,332		7,783,332		0.45
July 31, 2019		1.00		1,166,667		1,166,667		1.27
July 31, 2019		1.50		508,333		508,333		1.95
July 31, 2019		1.50		800,000		800,000		1.96
August 22, 2019		0.80		5,237,720		4,459,942		2.15
August 22, 2019		1.00		6,150,000		5,522,222		2.15
November 1, 2019		0.80		1,200,000		1,000,000		2.34
February 3, 2020		0.80		348,333		148,333		2.60
June 8, 2020		0.80		25,000		12,500		2.94
July 31, 2020		0.80		1,200,000		1,150,000		3.09
September 15, 2020		0.86		7,315,860		7,315,860		3.21
October 2, 2020		0.77		3,000,000		3,000,000		3.26
November 24, 2020		0.94		1,675,000		1,675,000		3.41
December 2, 2020		1.11		2,900,000		2,900,000		3.43
December 21, 2020		1.06		1,200,000		600,000		3.48
March 18, 2021		1.63		6,375,000		4,158,333		3.72
April 2, 2021		1.36		166,667		100,000		3.76
April 21, 2021		1.58		175,000		116,667		3.81
June 23, 2021		1.56		250,000		216,667		3.98
November 11, 2021		1.33		25,000		6,250		4.37
January 25, 2022		0.89		975,000		209,896		4.58
February 1, 2022		0.84		100,000		20,556		4.59
February 17, 2022		0.85		100,000		14,167		4.64
March 1, 2022		1.09		200,000		33,333		4.67
April 27, 2022		0.90		1,200,000		71,111		4.83
June 17, 2022		0.77		3,735,000		723,661		4.97
				60,057,752		49,958,670		2.72

Stock option activity is summarized as follows:

	Number of Options			Weighted Average Price CAD$		Weighted Average Years
Balance December 31, 2020		50,427,065			0.84		3.72
Granted		7,900,000			1.62		5.00
Exercised		(2,737,326	)		1.04		—
Forfeited/ Expired		(1,306,987	)		0.43		—
Balance December 31, 2021		54,282,752			0.94		2.97
Granted		6,435,000			0.83		5.00
Exercised		(51,975	)		0.80		—
Forfeited/ Expired		(608,025	)		1.62		—
Balance June 30, 2022		60,057,752			0.92		2.72

21

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

During the six months ended June 30, 2022 and 2021, the Company recognized share-based compensation of $1,428 and $5,375. During the three months ended June 30, 2022 and 2021, the Company recognized share-based compensation of $390and $2,979, respectively.

In determining the amount of equity-based compensation during the year, the Company used the Black-Scholes option pricing model to establish fair value of options granted during the year with the following key assumptions:

	2022			2021
Risk-Free Interest Rate		2.42	%		0.87	% to 0.92%
Expected Life (years)		5.00			5.00
Expected Annualized Volatility		71.30	%		86.2	% to 93.53%
Forfeiture rate		—	%		—	%
Expected Dividend Yield		—	%		—	%

Note 13: RELATED PARTIES

Related party transactions

LI Lending LLC

Linchpin Investors LLC (“Linchpin”), a subsidiary of the Company, and LI Lending LLC (“LI Lending”) entered into a Construction Loan Agreement dated May 10, 2019, as amended, whereby Linchpin received an

up-to

$45,000 loan from LI Lending of which $48,300 was outstanding as of December 31, 2021. Mr. Gontmakher, the CEO of the Company, and Roman Tkachenko, a director of the Company, each hold a 14.28% ownership interest in LI Lending. The loan matures in May 2024 and bears interest at 10.25%, payable monthly in cash. Upon maturity, an exit fee of $9 million is payable, for a total payable at maturity of $54 million. $49,457 of the loan advanced includes the notes payable and accrued interest less debt discount of $336 that was outstanding as of June 30, 2022. Of the $49,121 outstanding at June 30, 2022, $3,381 represents interest accrued through June 30, 2022. See Note 9 for details on the outstanding note payable.

Pure Ratios

Leonid Gontmakher, Chief Executive Officer of the Company, holds an interest in an entity related to iWolf Management, LLC, an online marketing company serving the online CBD market which provided online marketing services during 2020 and 2019 for the Company’s Pure Ratios division. Pure Ratios paid $313 for the three and six months ended June 30, 2021 to this vendor for management fees, pass through marketing costs and customer service. Pure Ratios did not make any such payments during the six months ended June 30, 2022.

MP Illinois

The Company maintains a contractual relationship with entities that are wholly owned by MP Illinois, a single-member LLC owned by Mr. Joshua N. Rosen, a former officer and director of the Company. The Company holds a nominee agreement whereby the Company receives a 100%

beneficial (but not legal) interest IL Grown Medicine, LLC, the holder of a cultivation license in Illinois.

22

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 14: CONTINGENCIES

(a) Cannabis Industry

Cannabis is still considered a Schedule

I

 substance under the Controlled Substance Act. As such, there is an inherent risk related to the federal government’s position on cannabis; additionally, the risk exists, due to the Company’s business in cannabis, that third party service providers could suspend or withdraw services and as well as the risk that regulatory bodies could impose certain restrictions on the issuer’s ability to operate in the U.S.; however, the Company has deemed it not reasonable to estimate a potential liability related to the possible enforcement of laws against the medical cannabis industry.

(b) Contingent consideration payable

As part of the acquisition of Om of Medicine, LLC and Cannex’s prior acquisition of Pure Ratios, the Company is subject to contingent consideration payable to the sellers. The fair value of the contingent consideration, which is based on specific revenue levels achieved over a

2-3-year

period, is as follows:

	Om of Medicine
Balance, December 31, 2021	$	2,393
Changes in fair value		(2,393	)
Balance, June 30, 2022		—
Less: current portion		—
Long-term portion	$	—

The contingent consideration payable is measured at fair value based on unobservable inputs and is considered a Level 3 financial instrument. The determination of the fair value of these liabilities is primarily driven by the Company’s expectations of the respective subsidiaries achieving certain milestones. The expected milestones were assigned probabilities and the expected related cash flows were discounted to derive the fair value of the contingent consideration. The Company reached expected milestones during the year ended December 31, 2021, which resulted in a contingent consideration payment of $

1,373

that was due to be paid by the Company in 2022. The Company paid

$

412

of the outstanding balance in April 2022. As discussed in Note 9, in April 2022, the Company entered into a seller note to pay the outstanding balance of the liability. The term of the note expires in six months and accrues interest at 10% per annum. See Note 9 for the outstanding balance of the note payable as of June 30, 2022.

The Company had an outstanding balance of contingent consideration of $2,393

for the period ended December 31, 202

1

, which included the liability noted above. However, the Company performed analyses and determined that it does not anticipate the subsidiaries to reach the required milestones, as detailed below, for the year ended December 31, 2022. As a result, the Company estimated the contingent consideration to be $nil as of June 30, 2022.

OM of Medicine:

The contingent consideration payable is determined as the amount in excess of gross sales o

f $3,400 (for fiscal 2021) and $3,500 (2022) to a maximum payable of $6,900.

23

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

(c) Legal Matters

From time to time, the Company may be involved in certain disputes arising in the ordinary course of business. Such disputes, taken in the aggregate, are not expected to have a material adverse effect on the Company. There are also no proceedings in which any of the Company’s directors, officers, or affiliates is an adverse party or has a material interest adverse to the Company’s interest.

On May 15, 2017, the Company’s wholly-owned subsidiary, 4Front Advisors, LLC, entered into an Application, Training, and Consulting Agreement with 5Seat Investment, LLC and Kanna. A dispute arose about amounts owed to the subsidiary under the agreement, and on May 17, 2022, the parties agreed to settle the matter for payment of $600 to the Company’s subsidiary.

On January 26, 2022, Savills

,

Inc. sued the Company in the U.S. District Court for the Southern District of New York. That lawsuit alleged that the Company had breached an alleged agreement with Savills under which the Company was allegedly required to pay Savills a percentage of savings realized under certain incentive programs offered in some jurisdictions, which Savills would assist the Company in obtaining. Savills claimed damages of approximately

$

19,000

in connection with its claim that it obtained benefits for the Company allegedly valued at over

$

129,000

.

The Company denied these allegations, denied the Company had obtained such benefits, disputed Savills’ characterization of the facts, and denied liability. The Company filed a counterclaim against Savills alleging breach of contract by Savills. On August 3, 2022, the parties reached a confidential settlement in principle and agreed to dismissal of all claims. In accordance with the order of dismissal, if no application to restore the litigation is submitted by September 6, 2022, the case will be dismissed without prejudice.

Note 15: FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

ASC 820, Fair Value Measurements, provides guidance on the development and disclosure of fair value measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles in the United States of America, and expands disclosures about fair value measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:

Level 1	Quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2	Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and
Level 3	Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

24

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the periods ended June 30, 2022 and December 31, 2021. The fair value of the Company’s cash, accounts receivable, other receivables, accounts payable and accrued expenses approximates carrying value due to their short-term nature. The Company’s notes receivable, lease receivables, contingent consideration payable, derivative liabilities, convertible notes payable, construction finance liability and notes payable approximate fair value due to the instruments bearing market rates of interest or their short term nature. As the interest rates utilized to calculate these instruments approximates market value interest rates, the carrying amounts of the instruments approximate fair value, which are primarily based on Level 1 inputs. The fair value of stock options granted were estimated based on a Black-Scholes model during the periods ended June 30, 2022 and December 31, 2021. The estimated fair value of the derivative liabilities, which represent embedded put included in the convertible notes payable, represent Level 3 measurements.

The following table details the fair value measurements within the fair value hierarchy of the Company’s financial instruments, which includes the Level 3 liabilities:

	Fair value at June 30, 2022
	Total		Level 1		Level 2		Level 3
Liabilities:
Derivative liability	$	428	$	—	$	—	$	428
Total liabilities	$	428	$	—	$	—	$	428

	Fair value at December 31, 2021
	Total		Level 1		Level 2		Level 3
Liabilities:
Derivative liability	$	3,502	$	—	$	—	$	3,502
Total liabilities	$	3,502	$	—	$	—	$	3,502

The table below provides a summary of the changes in fair value of the derivative liabilities measured on a recurring basis using significant unobservable inputs (Level 3):

	For the Six Months Ended June 30,
	2022			2021
Derivative liability:
Balance, beginning of period	$	3,502		$	5,807
(Gain) loss on fair value of derivative liability		(3,074	)		2,843
Change in fair value of derivative liability upon exercise of warrants		—			(1,427	)
Balance, end of period	$	428		$	7,223

There were 0 transfers between fair value levels for the six months ended June 30, 2022 and the year ending December 31, 2021.

25

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

(a) Financial Risk Management

The Company is exposed in varying degrees to a variety of financial instruments related risks. The Board mitigates these risks by assessing, monitoring and approving the Company’s risk management processes.

(b) Credit Risk

Credit risk is the risk of loss associated with a counterparty’s inability to fulfill its payment obligations. The Company’s credit risk is primarily attributable to cash, lease receivables, other receivables, and notes receivable. The Company’s maximum credit risk exposure is equivalent to the carrying value of these instruments.

The risk exposure is limited to the carrying amounts at the statement of financial position date. The risk to cash deposits is mitigated by holding these instruments with regulated financial institutions. Lease receivables, notes receivables and other receivables credit risk arises from the possibility that principal and interest due may become uncollectible. The Company mitigates this risk by managing and monitoring the underlying business relationships.

The Company maintains cash with federally insured financial institutions. As of December 31, 2021, the Company exceeded federally insured limits by approximately $10,866. The Company did not exceed any federally insured limits at any of its financial institutions for the six months ended June 30, 2022. The Company has historically not experienced any losses in such accounts. As of June 30, 2022, the Company held approximately $9 in cash in a Canadian account that is denominated in C$.

As of June 30, 2022 and December 31, 2021, the maximum credit exposure related to the carrying amounts of accounts receivable, other receivable, notes receivable and lease receivables was $15,823 and $12,722, respectively.

(c) Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations associated with financial liabilities. The Company manages liquidity risk through the management of its capital structure. The Company’s approach to managing liquidity is to raise sufficient capital to settle obligations and liabilities when due.

The Company has the following obligations as of June 30, 2022, which are expected to be payable in the following respective periods:

	Less than 1 year		1 to 3 years		3 to 5 years		Greater than 5 years		Total
Accounts payable and accrued liabilities	$	19,422	$	1,200	$	0—	$	—	$	20,622
Convertible notes, notes payable and accrued interest		8,235		74,699		—		—		82,934
Contingent consideration payable		—		—		0—		—		—
Construction finance liability		—		16,000		—		—		16,000
Total	$	27,657	$	91,899	$	0—	$	—	$	119,556

(d) Interest Rate Risk

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

(e) Foreign Exchange Risk

The Company is exposed to exchange rate fluctuations between United States and Canadian dollars. The Company’s share price is denominated in Canadian dollars. If the Canadian dollar declines against the United States dollar, the United States dollar amounts available to fund the Company through the exercise of stock options or warrants will be less. The Company also has bank accounts with balances of $9 in Canadian dollars. The value of these bank balances if converted to U.S. dollars will fluctuate. While the Company maintains a head office in Canada where it incurs expenses primarily denominated in Canadian dollars, such expenses are a small portion of overall expenses incurred by the Company. The Company does not have a practice of trading derivatives and does not engage in “natural hedging” for funds held in Canada.

26

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

(f) Other Price Risk

Price risk is the risk of variability in fair value due to movements in equity or market prices. The Company is subject to risk of prices to its products due to competitive or regulatory pressures.

Note 16: SEGMENT INFORMATION

Reportable Segments

Operating segments are components of the Company that combine similar business activities, with activities grouped to facilitate the evaluation of business units and allocation of resources by the Company’s board of directors and management. As of June 30, 2022, the Company had 2 reportable segments:

• THC Cannabis – Production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to own dispensaries and third-party retail customers, ancillary services supporting wholesale operations, and retail sales direct to end consumers ; and 

• CBD Wellness – Pure Ratios which encompasses the production and sale of CBD products to third-party customers .

The results of each segment are regularly reviewed by the Company’s Chief Executive Officer, who is the Company’s chief operating decision maker, to assess the performance of the segment and make decisions regarding the allocation of resources. The Company’s chief operating decision maker uses revenue and net loss as measure of segment performance. There are no intersegment sales or transfers. All revenues are derived from customers domiciled in the United States and all assets are located in the United States.

The below table presents revenues, depreciation and amortization, and net (income) loss by type for the three and six months ended June 30, 2022 and 2021, as well as assets by type as of June 30, 2022 and December 31, 2021:

	Three Months Ended June 30,					Six Months Ended June 30,
	2022			2021		2022			2021
Net Revenues
THC Cannabis	$	28,195		$	26,396	$	53,978		$	48,544
CBD Wellness		244			725		509			1,547
Corporate		0—			0—		—			—
Total Net Revenues		28,439			27,121		54,487			50,091
Depreciation and Amortization
THC Cannabis		1,123			833		1,970			1,589
CBD Wellness		—			—		—			16
Corporate		0—			28		—			30
Total Depreciation and Amortization		1,123			861		1,970			1,635
Net (Income) Loss
THC Cannabis		3,846			1,003		4,102			3,841
CBD Wellness		(104	)		817		(119	)		820
Corporate		2,809			4,403		8,467			12,651
Total Net Loss	$	6,551		$	6,223	$	12,450		$	17,312

Assets	June 30, 2022		December 31, 2021
THC Cannabis	$	318,795	$	238,933
CBD Wellness		781		805
Corporate		881		15,801
Total Assets	$	320,457	$	255,539

Goodwill assigned to the THC Cannabis segment as of June 30, 2022 and December 31, 2021 was $42,037 and $23,155, respectively. Intangible assets, net assigned to the THC Cannabis segment as of June 30, 2022 and December 31, 2021 were $54,239 and $26,246, respectively.

The Company did 0t have any Goodwill or intangible assets assigned to the CBD Wellness segment as of June 30, 2022 and December 31, 2021.

27

4 FRONT VENTURES CORP.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the Six Months Ended June 30, 2022 and 2021 (unaudited)

(Amounts expressed in thousands of U.S. dollars except for share and per share data)

Note 17: SUPPLEMENTARY CASH FLOW INFORMATION

Changes in

non-cash

working capital:

	June 30, 2022			June 30, 2021
Changes in operating assets and liabilities
Accounts receivable and other receivables	$	(2,766	)	$	(815	)
Inventory		(5,302	)		(4,563	)
Prepaid expenses		(318	)		50
Deposits		222			(70	)
Accounts payable and accrued liabilities		4,939			65
Taxes payable		5,683			5,163
	$	2,458		$	(170	)

Supplemental disclosure of

non-cash

investing and financing activities:

	June 30, 2022		June 30, 2021
Exchange of convertible debt to equity	$	3,122	$	17,719
Change in right-of-use assets and lease liabilities	$	8	$	153
Issuance of equity to pay contingent consideration	$	—	$	883
Issuance of debt to pay contingent consideration	$	—	$	485
Equity portion of warrants recorded through derivative liability	$	—	$	1,427
Issuance of equity for NECC pursuant to acquisition	$	18,200	$	—
Property, plant, and equipment acquired through NECC acquisition	$	15,238	$	—
Issuance of notes payable through NECC acquisition	$	2,000	$	—
Inventory acquired through NECC acquisition	$	213	$	—
Issuance of equity for Island pursuant to acquisition	$	6,245	$	—
Issuance of warrants for Island pursuant to acquisition	$	732	$	—
Property and equipment acquired through Island acquisition	$	2,214	$	—
ROU asset and lease liability acquired through Island acquisition	$	10,227	$	—
Note payable acquired through Island acquisition	$	245	$	—
Issuance of notes payable through Island acquisition	$	10,000	$	—
Inventory acquired through Island acquisition	$	3,072	$	—
Issuance of debt to acquire property and equipment	$	14	$	445
Inventory acquired through issuance of note payable	$	163	$	—
Cancellation of ROU asset and lease liability	$	2,020	$	—
Note payable issued to satisfy accrued expenses	$	961	$	—

• Cash paid for interest for the six months ended June 30, 2022 and 2021 was $3,174 and $1,662, respectively.

• Cash paid for income taxes for the six months ended June 30, 2022 and 2021 was $2,100 and $224, respectively.

Note 18: INCOME TAXES

The following table summarizes the Company’s income tax expense:

	For the Three Months Ended June						For the Six Months Ended June 30,
	2022			2021			2022			2021
Net loss before income taxes	$	(3,504	)	$	(2,867	)	$	(5,960	)	$	(11,298	)
Income tax expense		(3,042	)		(3,351	)		(6,480	)		(6,004	)

The Company has computed its provision for income taxes under the discrete method which treats the

year-to-date

period as if it were the annual period and determines the income tax expense or benefit on that basis. The discrete method is applied when application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. The Company believes the use of this discrete method is more appropriate than the annual effective tax rate method due to the early growth stage of the business. At this time, there is a high degree of uncertainty in estimating the Company’s annual

pre-tax

income and significant

non-deductible

expenses so the Company cannot reliably estimate the annual effective tax rate.

Internal Revenue Code (“IRC”) Section 280E denies, at the U.S. federal level, deductions, and credits attributable to a trade or business trafficking in controlled substances. Because the Company is subject to IRC Section 280E, the Company has computed its U.S. tax based on gross receipts less cost of goods sold. The tax provisions for the six months ended June 30, 2022 and 2021, have been prepared based on the assumption that cost of goods sold is a valid expense for income tax purposes.

The federal statute of limitation remains open for the 2018 tax year to the present. The state income tax returns generally remain open for the 2017 tax year through the present. Net operating losses arising prior to these years are also open to examination if and when utilized.

28

Note 19: SUBSEQUENT EVENTS

On July 13, 2022, Kathi Lentzsch resigned from her role as Chair of the Board, while remaining a Director and Chair of the Compensation Committee, and Mr. Robert Hunt was appointed Chair of the Board.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Quarterly Report on Form

10-Q

contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operating performance and may include statements concerning, among other things, our business strategy (including anticipated trends and developments in, and management plans for, our business and the markets in which we operate), financial results, the impact of

COVID-19

on our business, operations, and the markets and communities in which we, our clients, and partners operate, results of operations, revenues, operating expenses, and capital expenditures, sales and marketing initiatives and competition. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “suggests,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These statements are not guarantees of future performance; they reflect our current views with respect to future events and are based on assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from expectations or results projected or implied by forward-looking statements.

We discuss many of these risks in other filings we make from time to time with the Securities and Exchange Commission (the “SEC”). Also, these forward-looking statements represent our estimates and assumptions only as of the date of this Quarterly Report on Form

10-Q,

which are inherently subject to change and involve risks and uncertainties. Unless required by federal securities laws, we assume no obligation to update any of these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated, to reflect circumstances or events that occur after the statements are made. Given these uncertainties, investors should not place undue reliance on these forward-looking statements.

Investors should read this Quarterly Report on Form

10-Q

and the documents that we reference in this report and have filed with the SEC and on SEDAR, including Annual Report on Form

10-K,

filed with the SEC on April 18, 2022, with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements for the for the six months ended June 30, 2022 and 2021.

Unless the context otherwise indicates, when used in this Quarterly Report on Form

10-Q,

“4Front,” “the Company,” “we,” “us” and “our” refer to 4Front Ventures Corp., a British Columbia corporation, and its wholly owned subsidiaries on a consolidated basis.

Overview

4Front Ventures Corp. (“4Front” or the “Company”) exists pursuant to the provisions of the British Columbia Corporations Act. On July 31, 2019, 4Front Holdings LLC (“Holdings”) completed a Reverse Takeover Transaction (“RTO”) with Cannex Capital Holdings Inc. (“Cannex”) whereby Holdings acquired Cannex and the shareholders of Holdings became the controlling shareholders of the Company. Following the RTO, the Company’s SVS are listed on the Canadian Securities Exchange (“CSE”) under the ticker “FFNT” and are quoted on the OTC (OTCQX: FFNTF).

The Company has two primary operating segments: THC Cannabis and CBD Wellness. With regard to its THC Cannabis segment, as of June 30, 2022, the Company operates six dispensaries in Massachusetts, Illinois, and Michigan, primarily under the “MISSION” brand name. As of June 30, 2022, the Company operates three production facilities in Massachusetts, Illinois and California and produces the majority of products that are sold at its own Massachusetts and Illinois dispensaries. Also, as part of its THC Cannabis segment, the Company leases real estate and sells equipment, supplies and intellectual property to cannabis producers in the state of Washington.

29

While marijuana is legal under the laws of several U.S. states (with varying restrictions), the United States Federal Controlled Substances Act classifies all “marijuana” as a Schedule I drug, whether for medical or recreational use. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for the use of the drug under medical supervision.

The Company’s CBD Wellness segment is focused upon its ownership and operation of its wholly owned subsidiary, Pure Ratios Holdings, Inc. (“Pure Ratios”), a

CBD-focused

wellness company in California, that sells

non-THC

products throughout the United States.

Recent Developments

Merger with Island Global Holdings, Inc.

Please see Note 7 of the financial statements for a full description of the Company’s entrance into the Island Merger Agreement on March 30, 2022, and related transactions.

Changes to Composition of Board of Directors

On July 13, 2022, Kathi Lentzch resigned from her role as Chair of the Board, while remaining a Director and Chair of the Compensation Committee, and Mr. Robert Hunt was appointed Chair of the Board

Thut Resignation as Interim Chief Financial Officer

On June 9, 2022, Andrew Thut resigned his position as Interim Chief Financial Officer of the Company. Mr. Thut joined the Company in October 2014 as its Chief Investment Officer and was appointed to the position Interim Chief Financial Officer (in addition to his position as Chief Investment Officer) effective July 1, 2021. Mr. Thut will continue to serve as the Company’s Chief Investment Officer. Mr. Thut’s resignation from this position was not in connection with any known disagreement with the Company on any matter relating to the Company’s operations, policies, or practices, including accounting principles and practices.

Adams Appointment As Chief Financial Officer

Effective June 9, 2022, the Company’s board of directors appointed Keith Adams as the Company’s Chief Financial Officer. From November 2019 to present, Mr. Adams served as the Chief Financial Officer of LPF JV, LLC a privately-held California vertically integrated cannabis company that was recently acquired by StateHouse Holdings, Inc., formerly known as Harborside Inc. From July 2018 to November 2019, Mr. Adams worked as the Chief Accounting Officer of DionyMed Brands, Inc. (OTCMKTS: DYMEF), a multi-state cannabis brand, distribution and delivery platform supporting cultivators, manufacturers and brands in both medical and adult-use markets. From May 2016 to June 2018, Mr. Adams was the Chief Financial Officer at Efficient Power Conversion, a provider of gallium nitride (GaN)-based power management technology. Prior to this time, Mr Adams held various senior level finance jobs including CFO, CAO and others, mainly in the technology industry over the course of 25 years. Mr. Adams is licensed as a Certified Public Accountant and Certified Management Accountant. He also holds a Bachelor of Business Administration in Accounting from University of Wisconsin-Oshkosh.

There are no arrangements or understandings between Mr. Adams and any other persons pursuant to which he was appointed as an officer of the Company. Mr. Adams has no family relationships with any of the Company’s directors or executive officers, and, other than as described above, Mr. Adams does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation

S-K.

In connection with his appointment as Chief Financial Officer, Mr. Adams executed an offer letter pursuant to which the Company and Mr. Adams will enter into an employment agreement at a later date, with proposed terms that Mr. Adams would be entitled to an annual base salary of $275,000, eligible to earn

year-end

performance bonuses with a target bonus opportunity of 50% of his base salary, and an initial equity grant of 1,250,000 shares of the Company’s Subordinated Voting Shares, no par value per share, which would begin vesting in

one-third

increments beginning on the first anniversary of Mr. Adam’s first year of employment with the Company.

30

Feltham Termination

Effective June 14, 2022, the Company determined that the position of Chief Operating Officer was not needed at the present time, in order to further streamline the Company’s internal reporting structure. As such, Joseph Feltham was relieved of his duties as Chief Operating Officer of the Company, and a replacement for his position is not currently being pursued. The removal from employment of Mr. Feltham was not in connection with any known disagreement with the Company on any matter relating to the Company’s operations, policies or practices, including accounting principles and practices.

In connection with his removal from the Company, effective June 14, 2022 Mr. Feltham and the Company entered into a Separation, Transition, and Release of Claims Agreement (the “Feltham Separation Agreement”). The Feltham Separation Agreement was signed by all parties on July 14, 2022. Pursuant to the terms proposed by the Company for the Feltham Separation Agreement, Mr. Feltham will continue to receive a base salary of $11,538.46 bimonthly through December 31, 2022, and will retain the right to exercise previously vested options held by Mr. Feltham within 90 days of his termination date. Mr. Feltham is also eligible for a 2021 bonus payment

COVID-19

Pandemic

In March 2020, the World Health Organization (“WHO”) declared

COVID-19

a global pandemic, and the United States declared a national emergency with respect to

COVID-19.

The emergence of

COVID-19,

an extremely infectious airborne respiratory virus, caused a significant response on the part of many governments to contain it.

The full extent of the

COVID-19

pandemic impact continues to depend on future developments that remain highly uncertain and cannot be accurately predicted, including new information that may emerge concerning

COVID-19,

the actions taken to contain it or treat its impact, the identification and spread of

COVID-19

variants such as the Delta and the Omicron variants, the distribution of vaccines, the acceptance of vaccines and the implementation of vaccine mandates, and the economic impact on local, regional, national and international markets. Management continues to actively monitor the developments regarding the pandemic and the impact that the pandemic could have on our business, results of operations, financial condition, and most importantly the health and safety of our workforce. Given the continued volatility of the

COVID-19

pandemic and the global responses to curb its spread, we are not able to estimate the effects of the

COVID-19

pandemic on our results of operations, financial condition, or liquidity for 2022. Any recovery from negative impacts to our business and related economic impact due to the

COVID-19

pandemic may also be slowed or reversed by a number of factors, including the current widespread resurgence in

COVID-19

infections attributable to the Omicron variant, combined with the seasonal flu. As such, we are unable to reasonably estimate the duration of the pandemic or fully ascertain its long-term impact to our business.

War in Ukraine

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on our financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

Critical Accounting Policies and use of Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). We believe that several accounting policies are important to understanding our historical and future performance. We refer to these policies as critical because these specific areas generally require us to make judgments and estimates about matters that are uncertain at the time we make the estimate, and different estimates – which also would have been reasonable – could have been used. On an ongoing basis, we evaluate our estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and other market-specific or other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Critical accounting policies and estimates are further discussed in our Annual Report on Form

10-K

for the year ended December 31, 2021, as filed with the SEC on April 18, 2022.

31

Results of Operations

Three Months Ended June 30, 2022 Compared With Three Months Ended June 30, 2021

The following table sets forth our consolidated statement of operations for the three months ended June 30, 2022 and 2021, and the change between the two years ($ in thousands):

	For the Three Months Ended June 30,						Change
	2022			2021			$			%
Revenue from Sale of Goods	$	25,488		$	24,452		$	1,036			4	%
Real Estate Income		2,951			2,669			282			11	%
Total Revenues		28,439			27,121			1,318			5	%
Cost of Goods Sold		(16,123	)		(10,816	)		(5,307	)		49	%
Gross profit		12,316			16,305			(3,989	)		24	%
Total Operating Expense		16,415			15,637			778			5	%
Income (Loss) from Operations		(4,099	)		668			(4,767	)		714	%
Total Other income (expense), net		595			(3,535	)		4,130			117	%
Net Loss Before Income Taxes		(3,504	)		(2,867	)		(637	)		22	%
Income Tax Expense		(3,042	)		(3,351	)		309			9	%
Net Loss from Continuing Operations		(6,546	)		(6,218	)		(328	)		5	%
Net Loss	$	(6,546	)	$	(6,218	)	$	(328	)		5	%

Revenue from Sale of Goods

Revenue from sale of goods for the three months ended June 30, 2022 was $25,488, an increase of $1,036 or 4% compared to the three months ended June 30, 2021. This increase is primarily due to increased revenue from the Company’s Brookline, MA and Calumet City, IL dispensaries as well as an increase in the Company’s wholesale revenue as it ramps those portions of its business in California, Illinois, and Massachusetts.

Real Estate Income

Real Estate Income from leasing cannabis production facilities for the three months ended June 30, 2022 was $2,951, an increase of $282 or 11% which is relatively flat compared to the $2,669 recognized for the three months ended June 30, 2021.

Cost of Goods Sold

Cost of goods sold (“COGS”) increase $5,307 for the three months ended June 30, 2022 from $10,816 to $16,123. COGS represent costs to cultivate and produce cannabis and CBD products that are produced in our owned facilities and are sold to third parties and through our owned dispensaries. For products that are purchased from third parties, COGS is the cost of inventory for sales to retail customers. This increase in COGS is largely attributed to increased third-party purchases to meet consumer demand at the Company’s retail locations, as well as the acquisition of Island and the continued integration of both Island and NECC.

32

Gross Profit

Gross profit for the for the three months ended June 30, 2022 was $12,316 or 43% of revenue compared to $16,305 or 60% of revenue for the three months ended June 30, 2021. The decrease in gross profit percentage of 17% is primarily due to a larger contribution of revenue from the Company’s wholesale business, increases in third-party inventory purchases, particularly to meet exceptional consumer demand in IL, and some anticipated pricing pressure in the Massachusetts market. To mitigate the pricing pressures in Massachusetts, the Company has improved vertical sell-through in its retail locations, a benefit of the high-quality flower and “fresh frozen” products added via the NECC acquisition.

Total Operating Expenses

Total operating expenses for the three months ended June 30, 2022 were $16,415, an increase of $778 or 5%, as compared to the three months ended June 30, 2021. This increase is primarily due to an increase in general and administrative expenses of $1,483, attributable to the addition of new operations in Brookline, MA, Holliston, MA and CA since the comparable period, offset by a decrease in equity based compensation of $3,947.

Total Other Income (Expense), net

Total Other Income (Expense) for the three months ended June 30, 2022 was $595, as compared to $(3,535) for the three months ended June 30, 2021. This is primarily driven by an increase in other income attributable to the write-off of a contingent liability consideration and a change in the fair value of derivative liability.

Six Months Ended June 30, 2022 Compared With Six Months Ended June 30, 2021

The following table sets forth our consolidated statement of operations for the six months ended June 30, 2022 and 2021, and the change between the two years ($ in thousands):

	For the Six Months Ended June 30,						Change
	2022			2021			$			%
Revenue from Sale of Goods	$	48,571		$	44,532		$	4,039			9	%
Real Estate Income		5,916			5,559			357			6	%
Total Revenues		54,487			50,091			4,396			9	%
Cost of Goods Sold		(28,717	)		(19,941	)		(8,776	)		44	%
Gross profit		25,770			30,150			(4,380	)		15	%
Total Operating Expense		31,110			29,129			1,981			7	%
Income (Loss) from Operations		(5,340	)		1,021			(6,361	)		623	%
Total Other income (expense), net		(620	)		(12,319	)		11,699			95	%
Net Loss Before Income Taxes		(5,960	)		(11,298	)		5,338			47	%
Income Tax Expense		(6,480	)		(6,004	)		(476	)		8	%
Net Loss from Continuing Operations		(12,440	)		(17,302	)		4,862			28	%
Net Loss	$	(12,440	)	$	(17,302	)	$	4,862			28	%

Revenue from Sale of Goods

Revenue from sale of goods for the six months ended June 30, 2022 was $48,571, an increase of $4,039 or 9% compared to the six months ended June 30, 2021. This increase is primarily due to increased revenue from the Company’s Brookline, MA and Calumet City, IL dispensaries as well as an increase in the Company’s wholesale revenue as it ramps those portions of its business in California, Illinois, and Massachusetts.

33

Real Estate Income

Real Estate Income from leasing cannabis production facilities for the six months ended June 30, 2022 was $5,916, an increase of $357 or 6% which is relatively flat compared to the $5,559 recognized for the six months ended June 30, 2021.

Cost of Goods Sold

Cost of goods sold (“COGS”) increased $8,776 for the six months ended June 30, 2022 from $19,941 to $28,717. COGS represent costs to cultivate and produce cannabis and CBD products that are produced in our owned facilities and are sold to third parties and through our owned dispensaries. For products that are purchased from third parties, COGS is the cost of inventory for sales to retail customers. This increase in COGS is largely attributed to increased third-party purchases to meet consumer demand at the Company’s retail locations, as well as the acquisition of Island and the continued integration of both Island and NECC, is largely attributed to increased third-party purchases to meet consumer demand at the Company’s retail locations.

Gross Profit

Gross profit for the for the six months ended June 30, 2022 was $25,770 or 47% of revenue compared to $30,150 or 60% of revenue for the six months ended June 30, 2021. The decrease in gross profit percentage of 13% is primarily due to a larger contribution of revenue from the Company’s wholesale business, increases in third-party inventory purchases, particularly to meet exceptional consumer demand in IL, and some anticipated pricing pressure in the Massachusetts market. To mitigate the pricing pressures in Massachusetts, the Company has improved vertical sell-through in its retail locations, a benefit of the high-quality flower and “fresh frozen” products added via the NECC acquisition.

Total Operating Expenses

Total operating expenses for the six months ended June 30, 2022 were $31,110, an increase of $1,981 or 7%, as compared to the six months ended June 30, 2021. This increase is primarily due to an increase in general and administrative expenses of $3,962, attributable to the addition of new operations in Brookline, MA, Holliston, MA and CA since the comparable period offset by a decrease in equity based compensation of $3,947.

Total Other Income (Expense), net

Total Other Income (Expense) for the six months ended June 30, 2022 was $620, as compared to $12,319 for the six months ended June 30, 2021. This is primarily driven by a decrease in non-cash expenses including amortization of loan discount, change in fair value of derivative liability, and an increase in other income attributable to the write-off of a contingent liability consideration.

Non-GAAP

Financial and Performance Measures

In addition to providing financial measurements based on GAAP, we provide additional financial metrics that are not prepared in accordance with GAAP. Management uses

non-GAAP

financial measures, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company’s financial performance. Management uses the

non-GAAP

measurement of adjusted EBITDA, which we believe reflects our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as it facilitates comparing financial results across accounting periods. We also believe that this

non-GAAP

financial measure enables investors to evaluate the Company’s operating results and future prospects in the same manner as management. This

non-GAAP

financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company’s ongoing operating results. As there are no standardized methods of calculating

non-GAAP

measures, our methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others. Accordingly,

non-GAAP

measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP.

34

Adjusted EBITDA

Adjusted EBITDA is a financial measure that is not calculated in accordance with U.S. GAAP. Management believes that because adjusted EBITDA excludes (a) certain

non-cash

expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s core operating results over time (such as restructuring costs, litigation or dispute settlement charges or gains, and transaction-related costs), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. The Company’s management uses adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of adjusted EBITDA is not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net loss or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Although adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using

non-GAAP

measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are

non-cash

charges, the assets being depreciated and amortized will often have to be replaced in the future, and

non-GAAP

measures do not reflect any cash requirements for such replacements.

Adjusted EBITDA is defined by the Company as earnings before interest, taxes, depreciation and amortization, accretion, share-based compensation expense, legal settlement, change in value of derivative liability, foreign exchange gain (loss), loss on lease termination, other

non-cash

expenses, and

one-time

charges related to acquisition costs, financing-related costs, extraordinary

pre-opening

expenses and

non-recurring

expenses.

We consider these measures to be an important indicator of the financial strength and performance of our business. The following table reconciles adjusted EBITDA to its closest GAAP measure.

35

For the six months ended June 30, 2022 and 2021, adjusted EBITDA consisted of the following:

Six months ended June 30,	2022			2021
Net loss (GAAP)	$	(12,440	)	$	(17,302	)
Interest income		(2	)		(11	)
Interest expense		9,274			5,362
Amortization of loan discount upon conversion of debt to equity		—			2,915
Income tax expense		6,480			6,004
Depreciation and amortization		4,689			2,166
Accretion of liability expense		7,400			—
Equity based compensation		1,428			5,375
Change in contingent consideration payable		(2,393	)		—
Change in value of derivative liability		(3,074	)		2,843
Acquisition, transaction, and other one-time costs		3,010			3,054
Non-cash inventory adjustment		1,600			—
Non-cash lease expense		2,213			1,765
Loss on lease termination		—			1,210
Adjusted EBITDA (Non-GAAP)	$	18,185		$	13,381

For the three months ended June 30, 2022 and 2021, adjusted EBITDA consisted of the following:

Three months ended June 30,	2022			2021
Net loss (GAAP)	$	(6,546	)	$	(6,218	)
Interest income		—			(8	)
Interest expense		5,047			2,901
Amortization of loan discount upon conversion of debt to equity		—			—
Income tax expense		3,042			3,351
Depreciation and amortization		2,894			1,120
Accretion of liability expense		3,694			—
Equity based compensation		390			2,979
Change in contingent consideration payable		(2,393	)		—
Change in value of derivative liability		(1,774	)		311
Acquisition, transaction, and other one-time costs		2,119			1,558
Non-cash inventory adjustment		1,600			—
Non-cash lease expense		1,088			1,153
Loss on lease termination		—			331
Adjusted EBITDA (Non-GAAP)	$	9,161		$	7,478

Adjusted EBITDA should not be considered in isolation from, or as a substitute for, net loss. There are a number of limitations related to the use of adjusted EBITDA as compared to net loss, the closest comparable GAAP measure. Adjusted EBITDA excludes:

• Interest income and expense

• Current income tax expense

• Non-cash depreciation and amortization expense

• Accretion expense related to a periodic update of the present value of a liability

• Equity based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy

• Legal settlements

• Non-cash change in fair value of derivative liability

• Acquisition, transaction, and other expenses (income), which vary significantly by transaction and are excluded to evaluate ongoing operating results

36

Liquidity and Capital Resources

As of June 30, 2022 and December 31, 2021, we had total current liabilities of $63,392 and $48,838, respectively, and current assets of $47,125 and $50,874, respectively, to meet our current obligations. As of June 30, 2022, we had working deficit of $16,267, compared to working capital of $2,036, as of December 31, 2021. The decrease of $18,303 is driven primarily by a decrease in cash and increases in accounts payable and taxes payable, partially offset by increases in accounts receivable, other receivables, and inventory, and decreases in accrued expenses and other current liabilities, derivative liability, and current portion of convertible notes.

The Company is an early-stage growth company. It is generating cash from sales and is deploying its capital reserves to acquire and develop assets capable of producing additional revenues and earnings over both the immediate and near term. Capital reserves are being utilized for capital expenditures and improvements in existing facilities, product development and marketing, as well as customer, supplier and investor and industry relations.

Cash Flows

Net Cash (Used in) Provided by Operations

Net cash used in operating activities was $2,884 for the six months ended June 30, 2022, a decrease of $7,151 as compared to $4,267 of net cash provided by operating activities for the six months ended June 30, 2021. The decrease is due to a gain recognized on the fair valuation of the Company’s derivative liability compared to a loss in prior period and a prior period amortization of loan discount upon conversion of debt to equity, which was a one-time expense that was not incurred during the six months ended June 30, 2022. Additionally, the Company’s management of working capital resulted in a decrease in net working capital of $2,458.

Net Cash Used in Investing Activities

Net cash used in investing activities was $26,680 for the six months ended June 30, 2022, an increase of $15,944 as compared to $10,736 of cash used in investing activities for the six months ended June 30, 2021. The increase is primarily due to cash paid by the Company as part of the NECC acquisition for the six months ended June 30, 2022 as well as purchases of property, plant, and equipment of $2,249. The Company did not enter into an acquisition during the six months ended June 30, 2021. This increase is partially offset by more purchases of property and equipment by the Company during the six months ended June 30, 2021 than the six months ended June 30, 2022.

Net Cash Provided by Financing Activities

Net cash provided by financing activities was $13,015 for the six months ended June 30, 2022, an increase of $13,915 as compared to $900 of cash used in financing activities for the six months ended June 30, 2021. The increase is attributed to proceeds from the construction finance liability associated with the NECC acquisition during the six months ended June 30, 2022 of $16,000, partially offset by repayments of notes payable during the six months ended June 30, 2022 of $2,656.

37

Off-Balance

Sheet Arrangements

We do not have any

off-balance

sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Policies

We review new accounting standards as issued. Although some of these accounting standards issued or effective after the end of our previous fiscal year may be applicable to the Company, we have not identified any standards that we believe merit further discussion. We do not expect the adoption of any recently issued accounting pronouncements to have a significant impact on our financial position, results of operations, or cash flows.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company” as defined by Item 10 of Regulation

S-K,

the Company is not required to provide information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule

13a-15

under the Exchange Act, our management has carried out an evaluation, with the participation and under the supervision of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2022. Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating and implementing possible controls and procedures.

Material Weaknesses

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

Material Weaknesses in Internal Control

The Company did not fully design and implement effective control activities based on the criteria established in the COSO framework. The Company has identified deficiencies that constitute a material weakness, either individually or in the aggregate. This material weakness is attributable to the following factors:

• We did not have sufficient accounting staff resources to timely perform closing and audit-related procedures.

• We did not have effective controls over the review procedures for balance sheet account reconciliations and manual journal entries.

• We did not have documented evidence of review procedures and did not have sufficient segregation of duties within our accounting function.

Due to the existence of the above material weakness, management, including the CEO and CFO, has concluded that our internal control over financial reporting was not effective as of June 30, 2022. This material weakness creates a reasonable possibility that a material misstatement to the consolidated financial statements will not be prevented or detected on a timely basis.

Management conducted its evaluation of disclosure controls and procedures under the supervision of our CEO and CFO. Based upon, and as of the date of, this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of June 30, 2022 due to the material weaknesses listed above.

38

Remediation of Material Weaknesses in Internal Control over Financial Reporting

The Company continues to strengthen our internal control over financial reporting and is committed to ensuring that such controls are designed and operating effectively. The Company is implementing process and control improvements to address the above material weakness as follows:

• The Company will assess sufficient resources, both in accounting staff and related technology, needed to timely perform closing and audit-related procedures and align identified resources.

• The Company will assess controls needed to effectively review procedures for balance sheet account reconciliations and manual journal entries and implement identified controls.

• The Company will assess review procedures to have sufficient segregation of duties within our accounting function, then standardize and document such procedures for evidence of review.

The material weakness in the Company’s internal control over financial reporting will not be considered remediated until the remediated controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. The Company is working to have the material weaknesses remediated as soon as possible. However, there is no assurance that the remediation will be fully effective. As described above, the material weakness has not been remediated as of the filing date of this Form

10-Q.

If these remediation efforts do not prove effective and control deficiencies and material weaknesses persist or occur in the future, the accuracy and timing of the Company’s financial reporting may be materially and adversely affected.

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in Internal Control over Financial Reporting

The Company has begun implementing changes to strengthen the Company’s internal controls, including the hiring of a permanent CFO and Director of External Reporting, evaluating systems that could aid in improving controls, and implementing month end close procedures that include monthly flux analysis, Gross Margin analysis and performing balance sheet reconciliations. Other than those described above, there have been no changes in the Company’s internal control over financial reporting during the three months ended June 30, 2022 that have materially affected, or that are reasonably likely to materially affect, the Company’s internal control over financial reporting.

39

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

On May 15, 2017, the Company’s wholly-owned subsidiary, 4Front Advisors, LLC, entered into an Application, Training, and Consulting Agreement with 5Seat Investment, LLC and Kanna. A dispute arose about amounts owed to the subsidiary under the agreement, and on May 17, 2022, the parties agreed to settle the matter for payment of $600 to the Company’s subsidiary.

On January 26, 2022, Savills, Inc. sued the Company in the U.S. District Court for the Southern District of New York. That lawsuit alleged that the Company had breached an alleged agreement with Savills under which the Company was allegedly required to pay Savills a percentage of savings realized under certain incentive programs offered in some jurisdictions, which Savills would assist the Company in obtaining. Savills claimed damages of approximately $19,000 in connection with its claim that it obtained benefits for the Company allegedly valued at over $129,000. The Company denied these allegations, denied the Company had obtained such benefits, disputed Savills’ characterization of the facts, and denied liability. The Company filed a counterclaim against Savills alleging breach of contract by Savills. On August 3, 2022, the parties reached a confidential settlement in principle and agreed to dismissal of all claims. In accordance with the order of dismissal, if no application to restore the litigation is submitted by September 6, 2022, the case will be dismissed without prejudice.

Apart from the foregoing and ongoing legal proceedings, from time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of the legal proceedings set forth herein may result in adverse decisions or settlements, management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows.

Item 1A. Risk Factors

As a “smaller reporting company” as defined by Item 10 of Regulation

S-K,

we are not required to provide information required by this Item.

40

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On January 14, 2022, pursuant to a settlement agreement to settle an unsecured promissory note with an outstanding balance of $3,213 at December 31, 2021, the Company issued 6,235,512 SVS to LJM Investment Group.

On January 28, 2022, pursuant to an agreement and plan of merger whereby New England Cannabis Corporation, Inc., a Massachusetts corporation (“NECC”) became a wholly owned subsidiary of the Company, the Company issued 28,571,428 SVS, with a deemed value of $1.05 per share, or a total estimated valuation of $30,000,000 to Mr. Kenneth V. Stevens, the sole owner of all of the issued and outstanding capital stock of NECC.

On April 25, 2022, pursuant to an agreement and plan of merger whereby Island Global Holdings, Inc., a California corporation (“Island”) became a wholly owned subsidiary of the Company, the Company issued an aggregate of 8,783,716 SVS and warrants to purchase 2,999,975 SVS at a price of $1.00 per SVS to certain shareholders and debtholders of Island.

The foregoing transactions did not involve any underwriters, any underwriting discounts or commissions, or any public offering. We believe the offers, sales, and issuances of the above securities were exempt from registration under the Exchange Act (including Regulation D promulgated thereunder) by virtue of Section 4(a)(2) of the Securities Act, because the issuance of securities to the recipients did not involve a public offering. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access, through their relationships with us or otherwise, to information about us. The issuances of these securities were made without any general solicitation or advertising.

The Company did not repurchase any shares during the reporting period.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

The Company advanced its annual shareholder meeting from December to June, and held its annual shareholder meeting on June 22,

2022.

41

Item 6. Exhibits

Exhibit Number	Exhibit Description	Form	Filing Date	Exhibit Number	Filed Herewith
31.1	Certification of the Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act				x
31.2	Certification of the Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act				x
32.1	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13a-14(b) Under the Securities Exchange Act of 1934 and Section 1350 of Chapter 60 of Title 18 of the United States Code *				x
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

+ Indicates management contract or compensatory plan.

* This certification is being furnished solely to accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350, and it is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	4FRONT VENTURES CORP.
Date: August 15, 2022	By:	/s/ Leo Gontmakher
		Leo Gontmakher
		Chief Executive Officer and Director
		(Principal Executive Officer)
Date: August 15, 2022	By:	/s/ Keith Adams
		Keith Adams
		Chief Financial Officer
		(Principal Financial Officer)

43